The integrated genomic and transcriptomic analysis of the tumors showed EGFR, PDGFRA, FGFR3, NF1, and BRAF/RAF1 mutually exclusive alterations within the glioblastoma IDH-wild-type category (Figure 1 and Table S1). The gene discussed is FGFR3; the disease is glioblastoma.